K. Kaji

769 total citations
11 papers, 529 citations indexed

About

K. Kaji is a scholar working on Pathology and Forensic Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, K. Kaji has authored 11 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in K. Kaji's work include Systemic Sclerosis and Related Diseases (5 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). K. Kaji is often cited by papers focused on Systemic Sclerosis and Related Diseases (5 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). K. Kaji collaborates with scholars based in Japan and United States. K. Kaji's co-authors include Kazuhiko Takehara, Manabu Fujimoto, Shinichi Sato, Minoru Hasegawa, Yasuhito Hamaguchi, F. Ogawa, Kazuhiro Komura, Takashi Matsushita, Miki Kondo and Yutaka Saito and has published in prestigious journals such as Journal of Hepatology, British Journal of Dermatology and Lara D. Veeken.

In The Last Decade

K. Kaji

11 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Kaji Japan 7 402 234 209 153 103 11 529
Hidemitsu Orito Japan 6 290 0.7× 207 0.9× 90 0.4× 100 0.7× 55 0.5× 8 372
Chihiro Nishijima Japan 11 155 0.4× 105 0.4× 307 1.5× 93 0.6× 91 0.9× 15 424
Jean‐Baptiste Vulsteke Belgium 10 229 0.6× 112 0.5× 77 0.4× 48 0.3× 81 0.8× 20 319
Raffaele Bendo Italy 10 230 0.6× 150 0.6× 65 0.3× 51 0.3× 100 1.0× 13 381
Jean‐Luc Senécal Canada 8 196 0.5× 125 0.5× 89 0.4× 50 0.3× 112 1.1× 8 312
John D. Hendrix United States 11 207 0.5× 96 0.4× 115 0.6× 176 1.2× 20 0.2× 17 421
Vilma dos Santos Trindade Viana Brazil 7 121 0.3× 208 0.9× 98 0.5× 36 0.2× 107 1.0× 10 327
Kathleen M. David-Bajar United States 15 68 0.2× 297 1.3× 215 1.0× 169 1.1× 174 1.7× 20 564
Toshikazu Usuda Japan 9 71 0.2× 224 1.0× 250 1.2× 98 0.6× 90 0.9× 22 447
Masakazu Matsushita Japan 12 104 0.3× 228 1.0× 61 0.3× 29 0.2× 105 1.0× 53 391

Countries citing papers authored by K. Kaji

Since Specialization
Citations

This map shows the geographic impact of K. Kaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Kaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Kaji more than expected).

Fields of papers citing papers by K. Kaji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Kaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Kaji. The network helps show where K. Kaji may publish in the future.

Co-authorship network of co-authors of K. Kaji

This figure shows the co-authorship network connecting the top 25 collaborators of K. Kaji. A scholar is included among the top collaborators of K. Kaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Kaji. K. Kaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Yokota, Shin-ichi, K. Kaji, Tomohiro Yonezawa, Yasuyuki Momoi, & Shingo Maeda. (2023). CD204⁺ tumor-associated macrophages are associated with clinical outcome in canine pulmonary adenocarcinoma and transitional cell carcinoma. The Veterinary Journal. 296-297. 105992–105992. 5 indexed citations
2.
Maeda, Shingo, K. Kaji, Nozomu Yokoyama, et al.. (2019). Duodenal expression of antimicrobial peptides in dogs with idiopathic inflammatory bowel disease and intestinal lymphoma. The Veterinary Journal. 249. 47–52. 12 indexed citations
3.
Takaya, Hiroaki, K. Kaji, Soichiro Saikawa, et al.. (2018). Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. Journal of Hepatology. 68. S752–S752. 2 indexed citations
4.
Furukawa, Masashi, Soichiro Saikawa, Tadashi Namisaki, et al.. (2018). Sulforaphane Inhibits Liver Cancer Cell Growth and Angiogenesis. 4(2). 5 indexed citations
5.
Kaji, K., Noreen Fertig, Thomas A. Medsger, et al.. (2013). Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement. Arthritis Care & Research. 66(4). 575–584. 65 indexed citations
6.
Furuya, Y., et al.. (2010). Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis. Lara D. Veeken. 49(12). 2375–2380. 24 indexed citations
7.
Mugii, Naoki, Minoru Hasegawa, Chihiro Tanaka, et al.. (2009). Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis. Lara D. Veeken. 48(6). 696–703. 41 indexed citations
8.
9.
Hamaguchi, Yasuhito, Minoru Hasegawa, Manabu Fujimoto, et al.. (2008). The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. British Journal of Dermatology. 158(3). 487–495. 86 indexed citations
10.
Kaji, K., Manabu Fujimoto, Minoru Hasegawa, et al.. (2006). Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Lara D. Veeken. 46(1). 25–28. 219 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hidemitsu Orito Breakdown of academic impact, for papers by Chihiro Nishijima Breakdown of academic impact, for papers by Jean‐Baptiste Vulsteke Breakdown of academic impact, for papers by Raffaele Bendo Breakdown of academic impact, for papers by Jean‐Luc Senécal Breakdown of academic impact, for papers by John D. Hendrix Breakdown of academic impact, for papers by Vilma dos Santos Trindade Viana Breakdown of academic impact, for papers by Kathleen M. David-Bajar Breakdown of academic impact, for papers by Toshikazu Usuda Breakdown of academic impact, for papers by Masakazu Matsushita
Rankless by CCL
2026